Search Results Search Sort by RelevanceMost Recent Case and Commentary Feb 2003 Does Patient Autonomy Outweigh Duty to Treat? Catherine A. Marco, MD Patients can refuse medical treatment, but physicians often question the patients' ability to make a responsible decision in a time of medical need. Virtual Mentor. 2003;5(2):37-39. doi: 10.1001/virtualmentor.2003.5.2.ccas1-0302. In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408. In the Literature Jan 2003 Influence of Physician Bias on End-of-Life Care Michelle Lim A case study of nephrologists examines physicians' attitudes towards patients in advanced stages of kidney disease and how these attitudes affect the end-of-life care the patient receives. Virtual Mentor. 2003;5(1):13-15. doi: 10.1001/virtualmentor.2003.5.1.jdsc1-0301. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Viewpoint Aug 2004 Cosmetic Neurology: For Physicians the Future is Now Anjan Chatterjee, MD Medications for brain enhancement raise many ethical concerns regarding the roles of personal autonomy and responsibility. Virtual Mentor. 2004;6(8):367-371. doi: 10.1001/virtualmentor.2004.6.8.oped1-0408. Medicine and Society Oct 2004 Television on the Cutting Edge: Cosmetic Surgery Goes Prime-Time Leigh Turner, PhD Reality television programs that focus on cosmetic surgery show misguided viewers that such procedures are the key to emotional health and well-being. Virtual Mentor. 2004;6(10):462-464. doi: 10.1001/virtualmentor.2004.6.10.msoc1-0410. Pagination First page « First Previous page ‹ Previous … Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Current page 23
Case and Commentary Feb 2003 Does Patient Autonomy Outweigh Duty to Treat? Catherine A. Marco, MD Patients can refuse medical treatment, but physicians often question the patients' ability to make a responsible decision in a time of medical need. Virtual Mentor. 2003;5(2):37-39. doi: 10.1001/virtualmentor.2003.5.2.ccas1-0302.
In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408.
In the Literature Jan 2003 Influence of Physician Bias on End-of-Life Care Michelle Lim A case study of nephrologists examines physicians' attitudes towards patients in advanced stages of kidney disease and how these attitudes affect the end-of-life care the patient receives. Virtual Mentor. 2003;5(1):13-15. doi: 10.1001/virtualmentor.2003.5.1.jdsc1-0301.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Viewpoint Aug 2004 Cosmetic Neurology: For Physicians the Future is Now Anjan Chatterjee, MD Medications for brain enhancement raise many ethical concerns regarding the roles of personal autonomy and responsibility. Virtual Mentor. 2004;6(8):367-371. doi: 10.1001/virtualmentor.2004.6.8.oped1-0408.
Medicine and Society Oct 2004 Television on the Cutting Edge: Cosmetic Surgery Goes Prime-Time Leigh Turner, PhD Reality television programs that focus on cosmetic surgery show misguided viewers that such procedures are the key to emotional health and well-being. Virtual Mentor. 2004;6(10):462-464. doi: 10.1001/virtualmentor.2004.6.10.msoc1-0410.